Effectiveness of Bivalent mRNA Booster Vaccine Against COVID-19 in Korea.

Jin Gu Yoon Jang Wook Sohn Won Suk Choi Seong Heon Wie Jacob Lee Jin-Soo Lee Hye Won Jeong Joong Sik Eom Hye Seong Eliel Nham Yu Jung Choi Ji Yun Noh Joon Young Song Hee Jin Cheong Woo-Joo Kim

Published in: Journal of Korean medical science (2024)

The BA.4/BA.5-based bivalent mRNA booster vaccine provided significant protection against COVID-19 in the Korean adults, especially in the older adults aged ≥ 65 years and in individuals with underlying medical conditions.

Keyphrases

coronavirus disease
sars cov
randomized controlled trial
healthcare
systematic review
physical activity
respiratory syndrome coronavirus